---
$id: https://graph.org.ai/products/commodity/51151608
$type: Product
source: UNSPSC
code: "51151608"
title: "Dicyclomine or dicycloverine"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dicyclomine or dicycloverine

**UNSPSC Code**: 51151608
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C19H35NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 4KV4X8IF6V, chemically known as cyclohexanecarboxylic acid, 1-cyclohexyl-, 2-(diethylamino)ethyl ester but more generally known as dicyclomine, which bears US NIH Compound Identifier 3042. European Medicines Agency schedules Dicycloverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07103MIG. The term DICYCLOVERINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules dicyclomine in its Anatomical Therapeutic Chemical (ATC) Classification. Dicyclomine bears US NLM identifiers UMLS ID C0012125 and NCI Concept Code C61720. SMILES: CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.

